LEP and breast carcinoma: Importantly, previous works have demonstrated that CYP1B1 is overexpressed in breast cancer cells [57] and that leptin upregulates CYP1B1 mRNA and protein expression in breast cancer [58], thus suggesting that increase in CYP1B1 expression may be one of the mechanisms for the pro‐tumoral activity of leptin.